Advanced or Metastatic Squamous Solid Tumors
Advanced or Metastatic Squamous Solid Tumors are a type of cancer that originates in squamous cells and has spread to other parts of the body, often leading to serious health issues.
Advanced Solid Tumors: ALE.P02 Treatment Study
We are investigating a new antibody-drug conjugate, ALE.P02, for adults with certain advanced solid tumors. The study aims to evaluate its safety and how well it may work against these tumors.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have advanced squamous non-small cell lung cancer (SqNSCLC), head and neck squamous cell carcinoma (HNSCC), esophageal squamous cell carcinoma (ESCC), or cutaneous squamous cell carcinoma (CSCC)?
- Are you currently pregnant or breastfeeding?
- Have you had major surgery in the last 4 weeks?
- Are you taking any medications that are known to affect liver enzymes, such as certain antibiotics or antifungals?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Institut Bergonie
3102 Oncologie Médicale et Pédiatrique
Bordeaux, France
Centre Hospitalier Universitaire De Lille
3105: Centre Investigation Clinique
Loos, France
Centre Hospitalier Regional De Marseille
3103 Centre d'Essais Précoces en Cancérologie
Marseille, France
Sponsor: Alentis Therapeutics AG
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.